New stock news | Mindray Medical (300760.SZ) submits listing application to Hong Kong Stock Exchange

According to the Wise Finance APP, the Hong Kong Stock Exchange disclosed on November 10th that Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (hereinafter referred to as Mindray Medical, 300760.SZ) has submitted an application to the main board of the Hong Kong Stock Exchange, with Huatai International and JPMorgan Chase as its joint sponsors. According to the prospectus, the company is a leading, innovative world-class medical device enterprise and a leader in medical digitization. According to Frost & Sullivan data, in the Chinese medical device industry, the company's market value in 2024 exceeds the sum of the leading domestic companies (second to fifth place), and its industrial revenue is more than double that of the second-ranked company. The company has risen to 23rd place among the world's top medical device companies, and its ranking continues to rise. It is the only Chinese company to be listed in the world's top 30 medical device companies, and one of the fastest companies to be listed since its establishment.